Biofrontera Earlier Announced Enrollment Of 1st Subject In Phase 1 Safety Study Evaluating Photodynamic Therapy With 3 Tubes Of Ameluz

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.